Orion Infusions (DHA:ORIONINFU) FCF Margin % : -1.19% (As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is Orion Infusions FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Orion Infusions's Free Cash Flow for the three months ended in Dec. 2023 was BDT-2.4 Mil. Orion Infusions's Revenue for the three months ended in Dec. 2023 was BDT202.7 Mil. Therefore, Orion Infusions's FCF Margin % for the quarter that ended in Dec. 2023 was -1.19%.

As of today, Orion Infusions's current FCF Yield % is -0.11%.

The historical rank and industry rank for Orion Infusions's FCF Margin % or its related term are showing as below:

DHA:ORIONINFU' s FCF Margin % Range Over the Past 10 Years
Min: -1.71 Med: 4.65 Max: 13.76
Current: -1.71

During the past 13 years, the highest FCF Margin % of Orion Infusions was 13.76%. The lowest was -1.71%. And the median was 4.65%.

DHA:ORIONINFU's FCF Margin % is ranked worse than
53.65% of 1027 companies
in the Drug Manufacturers industry
Industry Median: -0.42 vs DHA:ORIONINFU: -1.71

Orion Infusions FCF Margin % Historical Data

The historical data trend for Orion Infusions's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orion Infusions FCF Margin % Chart

Orion Infusions Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

FCF Margin %

Get a 7-Day Free Trial

6.72

6.16

0.88

3.14

-0.90

Orion Infusions Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
FCF Margin %	Get a 7-Day Free Trial															2.59	1.67	-7.71	0.39	-1.19

Competitive Comparison of Orion Infusions's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Orion Infusions's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Orion Infusions's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Orion Infusions's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Orion Infusions's FCF Margin % falls into.

Orion Infusions FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Orion Infusions's FCF Margin for the fiscal year that ended in Jun. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Jun. 2023 )	/	Revenue (A: Jun. 2023 )
	=	-7.255	/	810.153
	=	-0.90 %

Orion Infusions's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-2.403	/	202.732
	=	-1.19 %

Orion Infusions FCF Margin % Related Terms

Thank you for viewing the detailed overview of Orion Infusions's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Orion Infusions (DHA:ORIONINFU) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Orion Infusions Ltd (DHA:ORIONINFU) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Tejgaon Industrial Area, No. 153-154, Dhaka, BGD, 1208

Website

https://www.orioninfusion.com

Orion Infusions Ltd is a pharmaceutical company. It produces various types of intravenous fluids, rehydration solutions, electrolyte solutions, antimicrobial products, and other pharmaceutical products in Bangladesh. The products of the company include Dextrolac, Dextropac, Dextrosal, Dianak, Electro dex, fructose, Hartman, Intralipid, Manisol, Maprocin, Nidazyl, Orlev, Ortac, Plasmasol, Proliv, and Salpac. In addition, the company is also involved in activities related to cosmetics and toiletries, infrastructure development, real estate and construction, power, agro products, hospitality, textiles and garments, and aviation management sectors. Geographically, it operates in Bangladesh.

Orion Infusions (DHA:ORIONINFU) Headlines

No Headlines